Skip to main content

Table 1 Prevalence of NIV and long-term oxygen treatment in Helsinki University Hospital Area on 1.1.2018

From: The prevalence of non-invasive ventilation and long-term oxygen treatment in Helsinki University Hospital area, Finland

Prevalence per 100,000*

All patients

COPD

NMD

RCWD

OHS

ILD

Misc**

NIV

(N = 362)

26.7

3.4

6.0

2.4

13.3

0.1

1.6

LTOT

(N = 335)

24.6

12.4

0.1

0.4

0.2

5.1

6.3

NIV + LTOT

(N = 118)

8.7

4.1

0.1

1.1

2.5

0.1

0.7

All NIV and/or LTOT treatments

(N = 815)

60.0

20.0

6.3

4.0

16.0

5.3

8.5

  1. COPD, chronic obstructive pulmonary disease; NMD, neuromuscular disease; RCWD, restrictive chest wall disease; OHS, obesity-hypoventilation syndrome; ILD, interstitial lung disease; Misc, miscellaneous; NIV, non-invasive ventilation; LTOT, long-term oxygen treatment
  2. *Children under 16, patients with invasive mechanical ventilation or sleep apnea are excluded from the study
  3. **Misc group includes heart disease and cancer patients